← Eichor
Condition: Autologous Transplantation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autologous Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
NA · 1 location(s) · Yicheng Ma · NCT05882110REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Submandibular Gland Stem Cell Transplantation
Phase 1 · 1 location(s) · University Medical Center Groningen · NCT04593589Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Thera
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06140966Anterior Cruciate Ligament Reconstruction With a Periosteal - Patellar Tendon - Bone Autograft - The Kocabey Press-Fit T
Phase N/A · 1 location(s) · Ankara City Hospital Bilkent · NCT06190223Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Phase 2 · 18 location(s) · Canadian Cancer Trials Group · NCT05180097Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
Phase 3 · 4 location(s) · XenoTherapeutics, Inc. · NCT06223269Risk Stratification and MRD-driven Maintenance for MM After ASCT
NA · 4 location(s) · Peking University People's Hospital · NCT06697483Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)
Phase 2 · 1 location(s) · Peking University · NCT06347653Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible fo
NA · 1 location(s) · Centre Hospitalier Henri Duffaut - Avignon · NCT06789003Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched Wit
Phase 2 · 1 location(s) · Minovia Therapeutics Ltd. · NCT06017869VitD3 Supplementation in Patients With Multiple Myeloma
EARLY_Phase 1 · 1 location(s) · Amany Keruakous, MD, MS. · NCT05846880Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
NA · 1 location(s) · Peking University People's Hospital · NCT07187882A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · 270 location(s) · Janssen Research & Development, LLC · NCT05552222Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, I
NA · 1 location(s) · Henan Cancer Hospital · NCT07037537EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease
Phase 1/Phase 2 · 1 location(s) · ASTEROGENE Biomedical Co. Ltd. · NCT07168603Orphan Indications for CD19 Redirected Autologous T Cells
Phase 2 · 1 location(s) · Stephan Grupp MD PhD · NCT04276870Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Tr
Phase 2 · 1 location(s) · University of Utah · NCT05405387A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07106710Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · 117 location(s) · SWOG Cancer Research Network · NCT060229393D Facial Scanning for Evaluating Autologous Fat Grafting in Craniofacial Deformities
NA · 1 location(s) · Peking University · NCT06306326Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au
NA · 6 location(s) · Kuros Biosurgery AG · NCT04679844Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients
Phase 3 · 2 location(s) · Guangzhou Gloria Biosciences Co., Ltd. · NCT06514508Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Phase 1/Phase 2 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07607197A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Particip
Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05757245A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplan
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06679829A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Mye
Phase N/A · 5 location(s) · Bristol-Myers Squibb · NCT06698887Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration
Phase 1 · 1 location(s) · Beijing Tongren Hospital · NCT05445063
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.